As specialty drugs siphon employers’ benefit spend, prices of more common drugs are also climbing. Can PBMs be part of the cost cure or another pain point?
Menu
Contracting a Cure for Prescription Drug Costs
- Published
- July 11, 2017
- - 2:01 pm
